Hepatology is the medical specialty focused on the liver, biliary system and related disorders of hepatic metabolism, detoxification, protein synthesis, bile production and circulation. The liver receives blood from both the hepatic artery and portal vein and performs numerous functions essential to systemic physiology, including metabolism of nutrients and drugs, synthesis of plasma proteins, processing of bilirubin, regulation of lipid and glucose metabolism, bile production and immune surveillance.
Hepatology covers viral hepatitis, metabolic dysfunction-associated steatotic liver disease, alcohol-related liver disease, autoimmune liver disorders, cholestatic disease, cirrhosis, portal hypertension, liver tumours and acute or chronic liver failure. It also encompasses diseases of the bile ducts and gallbladder in contexts where they affect hepatic or biliary physiology. Because the liver processes substances arriving from the gastrointestinal tract, Hepatology is closely connected with Gastroenterology, metabolism, infectious disease, oncology, transplantation and pharmacology.
Liver injury can be acute or chronic and may produce different biochemical and structural patterns. Hepatocellular injury predominantly affects liver cells and can cause elevations of aminotransferases, while cholestatic disorders more strongly affect bile flow and may produce elevations in alkaline phosphatase and bilirubin. These laboratory patterns are useful for classification but do not by themselves establish a specific diagnosis.
Causes of liver injury include viral infection, alcohol, metabolic disease, autoimmune processes, medications and toxins, vascular disorders and inherited metabolic conditions. The liver has substantial regenerative capacity, so biochemical abnormalities do not necessarily indicate irreversible damage. Conversely, serious liver disease can sometimes progress with relatively few symptoms until substantial functional impairment develops. Hepatological assessment therefore combines biochemical testing with clinical history, imaging, serology and sometimes histological examination.
Hepatitis refers to inflammation of the liver and can arise from infectious, immune-mediated, toxic, metabolic and other causes. Viral hepatitis includes infections caused by hepatitis A, B, C, D and E viruses, which differ substantially in transmission, natural history, chronicity and prevention. Hepatitis B and hepatitis C can become chronic and contribute to fibrosis, cirrhosis and hepatocellular carcinoma.
Hepatitis A generally does not become chronic, while hepatitis D requires hepatitis B infection because it depends on hepatitis B surface antigen for its lifecycle. Hepatitis E is usually acute but can cause severe disease in particular populations and chronic infection in some immunosuppressed people. Diagnosis depends on specific antigen, antibody and nucleic-acid tests rather than a generic “hepatitis test”. Vaccination is available for some hepatitis viruses, while antiviral therapy is an important component of management for selected chronic viral infections.
Steatotic liver disease involves excessive fat accumulation in liver cells and can range from relatively limited steatosis to inflammatory disease with fibrosis and eventual cirrhosis. Metabolic dysfunction-associated steatotic liver disease is associated with metabolic risk factors such as obesity, insulin resistance, type 2 diabetes and dyslipidaemia, although disease can occur across a broader range of body sizes and metabolic profiles. Alcohol-related liver disease results from harmful alcohol exposure and can manifest as steatosis, alcoholic hepatitis, fibrosis or cirrhosis.
Fibrosis represents deposition and remodelling of extracellular matrix within the liver and is a major determinant of long-term risk. Progression varies substantially between individuals and depends on underlying cause, duration of injury, metabolic factors, genetics and other influences. Management focuses on addressing the cause and reducing progression, with lifestyle intervention and treatment of associated metabolic disease important in appropriate patients.
Cirrhosis is an advanced pattern of chronic liver disease characterised by extensive fibrosis and architectural distortion of the liver. It can impair hepatic synthetic function and alter blood flow through the portal circulation. Portal hypertension may produce complications including ascites, splenomegaly, varices and hepatic encephalopathy. Variceal bleeding can be life-threatening because increased portal pressure promotes development of fragile collateral blood vessels, particularly in the oesophagus and stomach.
Ascites results from complex interactions among portal hypertension, sodium and water retention and reduced effective circulating volume. Hepatic encephalopathy involves neurological dysfunction associated with liver disease and altered handling of neuroactive substances, with precipitating factors such as infection, gastrointestinal bleeding, constipation or medication effects sometimes contributing. Cirrhosis can remain compensated for a prolonged period before decompensating, and the transition to decompensation substantially changes prognosis and management.
Liver function testing requires careful terminology because commonly ordered “liver function tests” measure a mixture of injury markers, cholestasis markers and indicators of hepatic synthetic capacity. Albumin and prothrombin time or international normalised ratio provide information about synthetic function, while bilirubin reflects processing and excretion of haemoglobin breakdown products as well as other processes. Aminotransferases indicate hepatocellular injury but are not direct measurements of liver function. Alkaline phosphatase and gamma-glutamyl transferase can support evaluation of cholestatic or biliary disease.
Imaging methods such as ultrasound, computed tomography and magnetic resonance imaging assess liver structure, vessels and focal lesions. Elastography can estimate liver stiffness and help assess fibrosis without requiring biopsy in many circumstances. Liver biopsy remains useful when histological information is necessary and non-invasive assessment cannot answer the clinical question.
Hepatocellular carcinoma is the most common primary malignant tumour of the liver and frequently arises in the setting of chronic liver disease and cirrhosis, although it can occur without cirrhosis in selected circumstances. Surveillance is recommended for particular high-risk populations according to clinical guidelines and may involve ultrasound with or without additional testing depending on the risk group. Diagnosis of liver tumours can involve multiphasic imaging, tumour markers and biopsy when necessary.
Treatment options depend on tumour number, size, vascular involvement, liver function and overall health and can include surgical resection, liver transplantation, local ablation, transarterial procedures and systemic therapies. Hepatology also manages benign liver lesions and cystic conditions, which require differentiation from malignant disease and may not require treatment. Accurate characterisation prevents both unnecessary intervention and delayed diagnosis of clinically significant lesions.
Liver transplantation is an established treatment for selected patients with irreversible advanced liver disease or particular acute liver failures. Candidate assessment considers severity of liver disease, complications, underlying cause, other medical conditions, cancer status and the risks and benefits of transplantation. After transplantation, immunosuppressive medicines are required to reduce rejection, but they increase susceptibility to infection and can cause metabolic, renal and other adverse effects. Living-donor and deceased-donor transplantation are used in appropriate settings, subject to medical and regulatory requirements.
Acute liver failure is distinct from chronic cirrhosis and can develop rapidly in people without pre-existing advanced liver disease, with causes including medications, toxins, viral infections and autoimmune disease. It can produce coagulopathy, encephalopathy and multiorgan dysfunction and may require urgent specialist assessment for transplantation. Hepatology therefore spans long-term disease management and highly time-sensitive critical care.
